Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?

Epidemiological data strongly support the inverse association between high-density lipoprotein cholesterol concentration and cardiovascular risk. Over the last three decades, pharmaceutical strategies have been partially successful in raising high-density lipoprotein cholesterol concentration, but c...

Descripción completa

Detalles Bibliográficos
Autor principal: Whyte, Martin B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691666/
https://www.ncbi.nlm.nih.gov/pubmed/31448115
http://dx.doi.org/10.1177/2048004019869736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691666/
https://www.ncbi.nlm.nih.gov/pubmed/31448115
http://dx.doi.org/10.1177/2048004019869736

Ejemplares similares